Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2019-01-32497,2019,Laske 2019 Otol Neurotol,18000,sequential cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- 41 to 64 years; Gender- Female; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 41 to 64 years; Gender- Female; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,20000,sequential cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- 41 to 64 years; Gender- Male; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 41 to 64 years; Gender- Male; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,24000,unilateral cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- >=65 years; Gender- Female; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- >=65 years; Gender- Female; Country- Switzerland.,unilateral cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,27000,sequential cochlear implantation VERSUS unilateral cochlear implantation IN Specific disease- hearing loss; Age- 19 to 40 years; Gender- Female; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 19 to 40 years; Gender- Female; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,unilateral cochlear implantation,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,28000,sequential cochlear implantation VERSUS unilateral cochlear implantation IN Specific disease- hearing loss; Age- 19 to 40 years; Gender- Male; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 19 to 40 years; Gender- Male; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,unilateral cochlear implantation,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,28000,unilateral cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- >=65 years; Gender- Male; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- >=65 years; Gender- Male; Country- Switzerland.,unilateral cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,31000,sequential cochlear implantation VERSUS unilateral cochlear implantation IN Specific disease- hearing loss; Age- 19 to 40 years; Gender- Female; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 19 to 40 years; Gender- Female; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,unilateral cochlear implantation,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,33000,sequential cochlear implantation VERSUS unilateral cochlear implantation IN Specific disease- hearing loss; Age- 19 to 40 years; Gender- Male; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 19 to 40 years; Gender- Male; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,unilateral cochlear implantation,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,36000,sequential cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- >=65 years; Gender- Female; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- >=65 years; Gender- Female; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,41000,sequential cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- >=65 years; Gender- Male; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- >=65 years; Gender- Male; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,43000,sequential cochlear implantation VERSUS unilateral cochlear implantation IN Specific disease- hearing loss; Age- 41 to 64 years; Gender- Female; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 41 to 64 years; Gender- Female; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,unilateral cochlear implantation,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,48000,sequential cochlear implantation VERSUS unilateral cochlear implantation IN Specific disease- hearing loss; Age- 41 to 64 years; Gender- Male; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 41 to 64 years; Gender- Male; Country- Switzerland.,sequential cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,unilateral cochlear implantation,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,6700,unilateral cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- 19 to 40 years; Gender- Female; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 19 to 40 years; Gender- Female; Country- Switzerland.,unilateral cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,6900,unilateral cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- 19 to 40 years; Gender- Male; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 19 to 40 years; Gender- Male; Country- Switzerland.,unilateral cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,8000,unilateral cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- 19 to 40 years; Gender- Female; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 19 to 40 years; Gender- Female; Country- Switzerland.,unilateral cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32497,2019,Laske 2019 Otol Neurotol,8500,unilateral cochlear implantation VERSUS hearing aids IN Specific disease- hearing loss; Age- 19 to 40 years; Gender- Male; Country- Switzerland.,31157721,Specific disease- hearing loss; Age- 19 to 40 years; Gender- Male; Country- Switzerland.,unilateral cochlear implantation,Age Dependent Cost-Effectiveness of Cochlear Implantation in Adults. Is There an  Age Related Cut-off?,hearing aids,NE
2019-01-32255,2019,Amirsadri 2019 Daru,40000,enoxaparin VERSUS Standard/Usual Care- Heparin IN Specific disease- medical inpatients; Age- Adult; Gender- Both; Country- Iran; Other- at risk for venous thromboembolism.,31368091,Specific disease- medical inpatients; Age- Adult; Gender- Both; Country- Iran; Other- at risk for venous thromboembolism.,enoxaparin,The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.,Standard/Usual Care- Heparin,NW
2019-01-32255,2019,Amirsadri 2019 Daru,59000,enoxaparin VERSUS Standard/Usual Care- Heparin IN Specific disease- medical inpatients; Age- Adult; Gender- Both; Country- Iran; Other- at risk for venous thromboembolism.,31368091,Specific disease- medical inpatients; Age- Adult; Gender- Both; Country- Iran; Other- at risk for venous thromboembolism.,enoxaparin,The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.,Standard/Usual Care- Heparin,NW
2019-01-32255,2019,Amirsadri 2019 Daru,64000,enoxaparin VERSUS Standard/Usual Care- Heparin IN Specific disease- medical inpatients; Age- Adult; Gender- Both; Country- Iran; Other- at risk for venous thromboembolism.,31368091,Specific disease- medical inpatients; Age- Adult; Gender- Both; Country- Iran; Other- at risk for venous thromboembolism.,enoxaparin,The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.,Standard/Usual Care- Heparin,NW
2019-01-32043,2019,Clement 2019 Bone Joint J,1600,robot-assisted unicompartmental knee arthroplasty VERSUS manual unicompartmental knee arthroplasty IN Specific disease- osteoarthritis; Age- Adult; Gender- Both; Country- United Kingdom; Other- Isolated medial compartment osteoarthritis.,31474149,Specific disease- osteoarthritis; Age- Adult; Gender- Both; Country- United Kingdom; Other- Isolated medial compartment osteoarthritis.,robot-assisted unicompartmental knee arthroplasty,Robot-assisted unicompartmental knee arthroplasty for patients with isolated medial compartment osteoarthritis is cost-effective: a markov decision analysis.,manual unicompartmental knee arthroplasty,NE
1 2 3 4 5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
